BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7731112)

  • 1. [Changes in smooth muscle cell proliferation in pulmonary arteries of rats given monocrotaline].
    Suzuki A; Kakusaka I; Kiyatake K; Nakano K; Kaneko N; Kuriyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Feb; 33(2):109-13. PubMed ID: 7731112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
    Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
    Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
    Altiere RJ; Olson JW; Gillespie MN
    J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
    Lappin PB; Roth RA
    Toxicol Pathol; 1997; 25(4):372-80. PubMed ID: 9280120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of pulmonary vascular endothelial cells to monocrotaline pyrrole: cell proliferation and DNA synthesis in vitro and in vivo.
    Lappin PB; Ross KL; King LE; Fraker PJ; Roth RA
    Toxicol Appl Pharmacol; 1998 May; 150(1):37-48. PubMed ID: 9630451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
    McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
    Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in main pulmonary artery of rats with monocrotaline-induced pulmonary hypertension.
    Guzowski DE; Salgado ED
    Arch Pathol Lab Med; 1987 Aug; 111(8):741-5. PubMed ID: 3115224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.
    Sahara M; Sata M; Morita T; Nakamura K; Hirata Y; Nagai R
    Circulation; 2007 Jan; 115(4):509-17. PubMed ID: 17242277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
    Ono S; Tanita T; Ashino Y; Noda M; Tabata S; Hoshikawa Y; Ueda S; Nishimura T; Fujimura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):441-5. PubMed ID: 8084100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
    Takahashi T; Kanda T; Imai S; Suzuki T; Kobayashi I; Nagai R
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):17-32. PubMed ID: 8824928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
    Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN
    Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension.
    Perros F; Dorfmüller P; Souza R; Durand-Gasselin I; Godot V; Capel F; Adnot S; Eddahibi S; Mazmanian M; Fadel E; Hervé P; Simonneau G; Emilie D; Humbert M
    Eur Respir J; 2007 May; 29(5):937-43. PubMed ID: 17182651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
    Gur S; Kadowitz PJ; Thammasitboon S; Lasky JA; Hellstrom WJ
    J Androl; 2009; 30(5):495-504. PubMed ID: 19201699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor.
    Cowan KN; Heilbut A; Humpl T; Lam C; Ito S; Rabinovitch M
    Nat Med; 2000 Jun; 6(6):698-702. PubMed ID: 10835689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid in pulmonary vascular structural remodeling in rats with pulmonary hypertension induced by monocrotaline.
    Qin Y; Zhou A; Ben X; Shen J; Liang Y; Li F
    Chin Med J (Engl); 2001 May; 114(5):462-5. PubMed ID: 11780404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
    Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
    Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1.
    Kimura H; Kasahara Y; Kurosu K; Sugito K; Takiguchi Y; Terai M; Mikata A; Natsume M; Mukaida N; Matsushima K; Kuriyama T
    Lab Invest; 1998 May; 78(5):571-81. PubMed ID: 9605182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Ito T; Okada T; Miyashita H; Nomoto T; Nonaka-Sarukawa M; Uchibori R; Maeda Y; Urabe M; Mizukami H; Kume A; Takahashi M; Ikeda U; Shimada K; Ozawa K
    Circ Res; 2007 Sep; 101(7):734-41. PubMed ID: 17673672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.